HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
351.44
+4.41 (1.27%)
Apr 3, 2025, 1:43 PM EDT - Market open

Company Description

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States.

It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities.

In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services.

The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Healthcare, Inc.
HCA Healthcare logo
Country United States
Founded 1968
Industry Medical Care Facilities
Sector Healthcare
Employees 316,000
CEO Samuel Hazen

Contact Details

Address:
One Park Plaza
Nashville, Tennessee 37203
United States
Phone 615 344 9551
Website hcahealthcare.com

Stock Details

Ticker Symbol HCA
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000860730
CUSIP Number 40412C101
ISIN Number US40412C1018
Employer ID 27-3865930
SIC Code 8062

Key Executives

Name Position
Samuel N. Hazen Chief Executive Officer and Director
Michael A. Marks Chief Financial Officer and Executive Vice President
Jon Mack Foster Executive Vice President and Chief Operating Officer
Michael R. McAlevey Executive Vice President and Chief Legal and Administrative Officer
Dr. Michael S. Cuffe M.B.A., M.D. Executive Vice President and Chief Clinical Officer
Dr. Thomas F. Frist Jr., M.D. Founder and Chairman Emeritus
Christopher F. Wyatt Senior Vice President, Principal Accounting Officer and Controller
Chad J. Wasserman Senior Vice President and Chief Information Officer
Frank George Morgan C.F.A. Vice President of Investor Relations
Wendy Warren Senior Vice President, Chief Ethics and Compliance Officer

Latest SEC Filings

Date Type Title
Mar 14, 2025 ARS Filing
Mar 14, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 14, 2025 DEF 14A Other definitive proxy statements
Mar 4, 2025 PRE 14A Other preliminary proxy statements
Feb 24, 2025 8-K Current Report
Feb 21, 2025 8-K Current Report
Feb 20, 2025 8-K Current Report
Feb 20, 2025 424B5 Filing
Feb 19, 2025 FWP Free Writing Prospectus
Feb 18, 2025 8-K Current Report